Use of specific dose of fondaparinux sodium for the treatment of acs

摘要

The the use of a dose of 2.5 mg of the pentasaccharide methyl O-(2-deoxy-2-sulfoamino-6-O-sulfo--D-glucopyranosyl)-(14)-O-(-D-glucopyranosyl uronic acid)-(14)-O-(2-deoxy-2-sulfoamino-3,6-di-O-sulfo--D-glucopyranosyl)-(14)-O-(2-O-sulfo-L-idopyranosyl uronic acid)-(14)-2-deoxy-2-sulfoamino-6-O-sulfo--D-glucopyranoside decasodium salt for the treatment of Acute Coronary Syndromes (ACS).